As mutations in P. vivax dhps and dhfr genes provide a valuable tool for epidemiological surveillance of SP resistance, the prevalence of point mutations on these genetic markers of SP resistance should be assessed for providing information for future treatment policy with alternative antifolate drugs because of the appearance and dispersion of CQ resistance in malaria endemic areas. Here, DHFR is linked to malaria.